Symbiotec IPO draws positive brokerage views on strong API portfolio growth
Symbiotec Pharmalab IPO is a mix of a fresh issue of ₹15 lakh and an offer for sale of ₹1.63 crore.
The price band for the offer is set issue price band at ₹938 to ₹988 per share.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.business-standard.com — the content belongs to Business Standard.
